                                                                                                                                                                           0                 1
                                                                                                                                  The application was received by the EMA on     25 March 2022
                                                                                                                                                    The procedure started on       19 May 2022
                                                                              The CHMP Rapporteur's first Assessment Report was circulated to all \nCHMP and PRAC members on     9 August 2022
                                         The CHMP Co-Rapporteur's critique on the CHMP Rapporteurâ€™s first \nAssessment Report was circulated to all CHMP and PRAC members on    23 August 2022
                                                                              The PRAC Rapporteur's first Assessment Report was circulated to all \nPRAC and CHMP members on    19 August 2022
                                                                   The CHMP agreed on the consolidated List of Questions to be sent to the \napplicant during the meeting on 15 September 2022
                                                                                       The applicant submitted the responses to the CHMP consolidated List of \nQuestions on  16 December 2022
          The CHMP Rapporteur circulated the CHMP and PRAC Rapporteurs Joint \nAssessment Report on the responses to the List of Questions to all CHMP \nand PRAC members on   30 January 2023
                                                                                  The PRAC agreed on the PRAC Assessment Overview and Advice to CHMP \nduring the meeting on   9 February 2023
                                                   The CHMP agreed on a list of outstanding issues in writing and/or in an \noral explanation to be sent to the applicant on  23 February 2023
                                                                                           The applicant submitted the responses to the CHMP List of Outstanding \nIssues on     24 March 2023
The CHMP Rapporteurs circulated the CHMP and PRAC Rapporteurs Joint \nAssessment Report on the responses to the List of Outstanding Issues to \nall CHMP and PRAC members on     13 April 2023
                                                                                                                                                                                          0             1
The CHMP, in the light of the overall data submitted and the scientific \ndiscussion within the Committee, issued a positive opinion for granting a \nmarketing authorisation to Columvi on 26 April 2023
                                                                                           The CHMP adopted a report on similarity of Columvi with Kymriah, \nYescarta, Minjuvi & Polivy on 26 April 2023
                                                Furthermore, the CHMP adopted a report on New Active Substance (NAS) \nstatus of the active substance contained in the medicinal product on 26 April 2023